Search results
The race for a weight loss pill heats up as a Novo Nordisk competitor releases new trial results
Quartz· 22 hours agoIt’s the latest development in the race among several pharmaceutical companies to introduce new ...
Structure Therapeutics (GPCR) Stock Soars 60% on Weight Loss Drug Success
InvestorPlace· 20 hours agoStructure Therapeutics (NASDAQ:GPCR) stock is surging today, up 60% after the biotech company...
Structure Therapeutics’ stock jumps on weight-loss-pill trial results
Market Watch· 1 day agogained more than 6% premarket on Monday after the company said its experimental weight-loss pill...
Structure pill leads to competitive weight loss in obesity study
BioPharma Dive via Yahoo Finance· 1 day agoShares in the company soared by more than 50% as study data showed the pill led to similar levels of...
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
Motley Fool via Yahoo Finance· 1 day agoThat puts its efficacy at roughly...Viking additionally has another clinical-stage program testing...
Jessica Simpson credits walking this many steps per day for 100-pound weight loss
TODAY via Yahoo News· 7 days agoJessica Simpson has been candid about her diet and fitness routines that helped her lose weight. Her...
Structure Therapeutics reports promising weight-loss drug data | Invezz
Invezz· 21 hours agoStructure Therapeutics Inc (NASDAQ: GPCR) is up a whopping 80% on Monday after reporting “compelling” topline data for its weight-loss drug. The biopharmaceutical ...
Are ‘Ozempic Babies’ Real? Here’s What We Know About the Link Between Weight Loss Drugs and...
PureWow via AOL· 23 hours ago“Yes, I was taking semaglutide, which is also known as Ozempic, and I got pregnant. So here’s your...
Is Compounded Ozempic Safe For Weight Loss? What You Need To Know
Forbes· 7 days agoWeight-loss treatments like semaglutide (Ozempic) and tirzepatide (Mounjaro) have been life changing...
Heard on the Street: Wall Street Is Cheering a New Obesity Pill Candidate. Here's Why.
The Wall Street Journal· 23 hours agoYou don’t need a home run to get Wall Street excited about a pill for obesity. When the market...